Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Castration Resistant Metastatic Prostate Cancer 2Uterine Cervical Neoplasms 1Neoplasms 1Fatigue 1Castration-resistant Prostate Cancer 1Castration-Resistant Prostate Carcinoma 1Carcinoma, Squamous Cell 1Cachexia 1

Interventions

Exercise 34Therapeutics 24Modafinil 18Yoga 16Surveys and Questionnaires 16Methylphenidate 14Psychiatric Rehabilitation 12Acupuncture Therapy 10Educational Status 9Cognitive Behavioral Therapy 8Walking 7Control Groups 7Ultraviolet Therapy 6Therapeutic Touch 6Physical Therapy Modalities 6Exercise Therapy 6Acceptance and Commitment Therapy 6Sugars 5Early Intervention, Educational 5Standard of Care 4Qigong 4Palliative Care 4Methods 4Behavior Therapy 4Acupressure 4methyl hydroxyethyl cellulose 3Touch 3Saline Solution 3Resistance Training 3Music Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fatigue × testosterone enanthate × Clear all
NCT00965341 2016-09-13

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 3 Completed
53 enrolled 8 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡